Table 5.
Inclusion levels of DON-contaminated DDGS1, % |
P-value4 |
||||||
---|---|---|---|---|---|---|---|
Items3 | 0 | 10 | 20 | SEM | T | L | Q |
Liver, % | 3.11a | 3.26a | 2.82b | 0.08 | <0.01 | 0.02 | <0.01 |
Breast, % | 19.81a | 20.98a | 18.10b | 0.01 | <0.01 | 0.03 | <0.01 |
Small intestine, % | 5.31 | 5.61 | 5.33 | 0.20 | 0.52 | 0.96 | 0.26 |
Kidney, % | 0.55 | 0.60 | 0.51 | 0.27 | 0.09 | 0.29 | <0.05 |
Spleen, % | 0.11 | 0.12 | 0.10 | 0.01 | 0.27 | 0.56 | 0.13 |
BF5, % | 0.22 | 0.22 | 0.20 | 0.05 | 0.51 | 0.30 | 0.63 |
Means within a variable with no common superscript differ significantly (P < 0.05).
DON, deoxynivalenol; DDGS, corn distillers dried grains with solubles.
Data are least squares means of 8 observations per treatment.
The relative organ weight was expressed as a percentage of BW.
T, overall effects of treatments; L, linear effects of increasing inclusion levels of DON-contaminated DDGS in diets; Q, quadratic effects of increasing inclusion levels of DON-contaminated DDGS in diets.
BF, bursa of Fabricius.